Furthermore, using CRISPR-mediated genetically engineered mouse models (CRISPRGEMMs) [20], Wang et al. found that KMT2D deficiency acts as an independent factor that sensitizes tumors to responses to ICIs for multiple cancer types. Here, KMT2D is linked to cancer.